Akero
  • Home
  • About
  • R & D
  • Efruxifermin
    • Efruxifermin Publications
  • What is Nash?
  • Contact
  • Terms of Use
  • Menu Menu

FGF21 acts as a negative regulator of bile acid synthesis

March 4, 2020/in Publications /by David Anderson
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2020-03-04 11:20:532020-03-04 11:20:53FGF21 acts as a negative regulator of bile acid synthesis
  • About
  • R & D
  • Efruxifermin
    • Efruxifermin Publications
  • Investors
  • What is Nash?
  • Contact
© 2020 Akero Therapeutics, Inc. All rights reserved. Terms of Use.
Scroll to top